Results 201 to 210 of about 3,383,112 (390)

The paradoxical adverse effect of verapamil for treating clinical paroxysmal supraventricular tachycardia.

, 1987
Tetsunori Saikawa, Ken‐ichi Inoue, Ichiro OHMURA, Sukenobu Ito, Hidetoshi Yonemochi, Mikiko Nakagawa, Morio Ito, Kyoichi Ohashi, Akio Ebihara   +8 more
openalex   +2 more sources

Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options. Transcranial direct current stimulation (tDCS) shows promise as a neuromodulatory intervention in various neurological disorders, but its application in ALS, particularly in a remote, home‐based format, remains underexplored.
Sangeetha Madhavan, Shravni Deshmukh, Mark Cummings, Aditi Doshi, Kourosh Rezania, Sally Freels, Gina Sawa   +6 more
wiley   +1 more source

Shiga Toxin—Producing Escherichia coli Urinary Tract Infection Associated with Hemolytic-Uremic Syndrome in an Adult and Possible Adverse Effect of Ofloxacin Therapy [PDF]

, 2000
Marcel Miédougé, J Hacini, Francine Grimont, Joseph Watine   +3 more
openalex   +1 more source

Management and Outcomes in Confirmed or Suspected Acute Symptomatic Seizure: Role of Structured Outpatient Care

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Post‐discharge management and outcomes of acute symptomatic seizures (ASyS) remain underexplored. We analyzed post‐discharge ASM management and outcomes in ASyS patients undergoing continuous EEG (cEEG), including the role of outpatient care through a post‐acute symptomatic seizure (PASS) clinic. Methods We performed a single‐center,
Vineet Punia, MarieElena Byrnes, Nicolas R. Thompson, Neishay Ayub, Clio Rubinos, Sahar Zafar, Adithya Sivaraju, Zhong Ying, Jessica R. Fesler, Stephen Hantus, Post‐Acute Symptomatic Seizure Investigation and Outcomes Network (PASSION) investigators   +10 more
wiley   +1 more source

Respiratory Alkalosis as an Adverse Effect of Safinamide? [PDF]

Eur J Case Rep Intern Med
Freitas F, Rosa B, Pinto Silva C, Marques C, Mota J, Lemos Costa C, Oliveira C.   +6 more
europepmc   +1 more source

Acid Reflux: A Rare Adverse Effect of Duloxetine. [PDF]

Cureus, 2023
Vaghela N, Jadav N, Kollampare S, Patel P, Oza M.   +4 more
europepmc   +1 more source

Repeated Acute Testing of Anticonvulsant Drugs in Amygdala Kindled Rats: Increase in Anticonvulsant But Decrease in Adverse Effect Potential [PDF]

, 2000
Wolfgang Löscher, Mia Fiedler
openalex   +1 more source

CSF Tau Is a Biomarker of Hippocampal Injury in Cryptogenic New‐Onset Refractory Status Epilepticus

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cryptogenic new‐onset refractory status epilepticus (cNORSE) is a devastating condition characterized by the de novo onset of status epilepticus with unclear etiology. The identification of relevant early biomarkers in cNORSE is important to elucidate pathophysiology, aid clinical decision‐making, and prognosticate outcomes in cNORSE.
Yihui Goh, Yoonhyuk Jang, Soo Jean Shin, Soo Hyun Ahn, Su Yee Mon, Yoon Hee Shin, Kon Chu, Sang Kun Lee, Soon‐Tae Lee   +8 more
wiley   +1 more source

No Adverse Effect of Non-Steroidal Anti-Inflammatory Drugs, Sulindac and Diclofenac Sodium, on Blood Pressure Control with a Calcium Antagonist, Nifedipine, in Elderly Hypertensive Patients.

, 1991
Kazuhisa Takeuchi, Keishi Abe, Minoru Yasujima, Makito Sato, Masaya Tanno, Koh Sato, KAORU YOSHINAGA   +6 more
openalex   +2 more sources

Clinical Trial Readiness in Limb Girdle Muscular Dystrophy R1 (LGMDR1): A GRASP Consortium Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying functional measures that are both valid and reliable in the limb girdle muscular dystrophy (LGMD) population is critical for quantifying the level of functional impairment related to disease progression in order to establish clinical trial readiness in the context of anticipated therapeutic trials.
Stephanie M. Hunn, Lindsay N. Alfano, Aileen Jones, Amanda Butler, Linda P. Lowes, Megan A. Iammarino, Natalie F. Reash, Lindsay Pietruszewski, Sandhya Sasidharan, Melissa Currence, Jeffrey M. Statland, Talia Strahler, Robert Will, Matthew Wicklund, Stacy Dixon, Renee Augsburger, Tahseen Mozaffar, Katie M. Laubscher, Shelley R. H. Mockler, Katherine D. Mathews, Nikia Stinson, Doris G. Leung, Molly M. Stark, Rebecca A. Horton, Peter B. Kang, Meredith K. James, Amanda Clause, Conrad C. Weihl, Nicholas E. Johnson, GRASP‐LGMD Consortium   +29 more
wiley   +1 more source